Qube Research & Technologies LTD Iveric Bio, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $12 Million - $18.1 Million	456,296 New	456,296 $18 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $1.67 Million - $3.29 Million	177,193 New	177,193 $3.18 Million
Q2 2020 Aug 14, 2020	SELL	$3.06 - $6.6 $196,950 - $424,795	-64,363 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $155,717 - $464,402	-55,024 Reduced 46.09%	64,363 $221,000
Q4 2019 Feb 13, 2020	BUY	$0.93 - $8.58 $111,029 - $1.02 Million	119,387 New	119,387 $1.02 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.